- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating
January 17, 2023
From MarketWatch
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
January 16, 2023
From Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
From Benzinga
New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says
January 13, 2023
From MarketWatch
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup
January 10, 2023
From Benzinga
China takes first steps to punish countries that imposed testing mandates for Chinese travelers
January 10, 2023
From MarketWatch
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
January 09, 2023
From Benzinga
XBB.1.5, which makes up 28% of new COVID cases in the U.S., fuels worries about a winter wave
January 06, 2023
From MarketWatch
2 Top Biotech Stocks to Buy Right Now
January 06, 2023
From Motley Fool
As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer
January 04, 2023
From MarketWatch
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
January 03, 2023
From Benzinga
Why BioNTech Was a Sickly Stock This Week
December 30, 2022
From Motley Fool
Three Pharma Stocks to Sell Before They Die
December 24, 2022
From InvestorPlace
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
December 21, 2022
Tickers
BNTX
From Benzinga
Federal spending bill’s pandemic provisions: more public health data, no investigation into COVID’s origin
December 21, 2022
From MarketWatch
Will Investors Notice Exciting Sign On BioNTech's Chart?
December 19, 2022
Tickers
BNTX
From Benzinga
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
December 18, 2022
From InvestorPlace
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
December 15, 2022
From MarketWatch
BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities
December 15, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
From Benzinga
Why Is Novavax (NVAX) Stock Plunging Today?
December 15, 2022
From InvestorPlace
Pfizer Expects $10-$15B From mRNA Vaccine Sales By 2030, Sees $17B Revenues Lost Due To Patent Expiry
December 13, 2022
From Benzinga
COVID cases continue upward march as new, more infectious variants emerge and flu, RSV and other respiratory illnesses spread
December 12, 2022
From MarketWatch
Omicron subvariants are now dominant in the U.S. as COVID cases tick up and New York City becomes a hot spot
December 09, 2022
From MarketWatch
FDA Authorizes Pfizer/BioNTech And Moderna's Bivalent COVID Shots For 6 Months Old
December 08, 2022
From Benzinga
US Supports Delay On COVID Patent Waiver Extension Decision
December 06, 2022
From Benzinga
From Benzinga
From Benzinga
China begins to loosen COVID rules
December 05, 2022
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.